With regard to using US manufacturing facilities f
Post# of 154282
(Total Views: 321)
Posted On: 06/18/2025 10:00:34 AM
With regard to using US manufacturing facilities for Leronlimab, PRs about manufacturing LL were released in 2020 by US manufacturers. I don’t know if there are any current agreements, but it can be done if needed to qualify for a Commissioner’s National Priority Voucher.
AGC Biologics (Seattle) for manufacturing make the drug.
https://www.agcbio.com/hs-search-results?term=CytoDyn
Ajinomoto Althea (San Diego) for aseptic fill-finish.
https://www.ajibio-pharma.com/news-post/ajino...al-trials/
Note: PCI Pharma Services purchased Ajinomoto Althea on 5/1/25.
https://pci.com/pci-pharma-services-completes...to-althea/
AGC Biologics (Seattle) for manufacturing make the drug.
https://www.agcbio.com/hs-search-results?term=CytoDyn
Ajinomoto Althea (San Diego) for aseptic fill-finish.
https://www.ajibio-pharma.com/news-post/ajino...al-trials/
Note: PCI Pharma Services purchased Ajinomoto Althea on 5/1/25.
https://pci.com/pci-pharma-services-completes...to-althea/
(9)
(0)